Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07196410
PHASE1
KAN-004 for Immune-Related Diarrhea or Colitis
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
View on ClinicalTrials.gov
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of KAN-004 in patients with immune-related colitis.
Official title: A Phase I Study of KAN-004 in Patients With Immune-Related Diarrhea or Colitis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
21
Start Date
2025-10-01
Completion Date
2030-12-31
Last Updated
2025-09-29
Healthy Volunteers
No
Interventions
BIOLOGICAL
KAN-004
Each dose of KAN-004 contains a consortium of bacteria isolated from the stool of healthy donors formulated as a powder in a capsule intended for oral administration
Locations (1)
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada